{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Influenza+Virus+Vaccine&page=29", "query": { "intervention": "Influenza Virus Vaccine", "page": 29 }, "page_size": 10 }, "pagination": { "page": 29, "page_size": 10, "total_count": 1125, "total_pages": 113, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Influenza+Virus+Vaccine&page=30&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Influenza+Virus+Vaccine&page=28&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-17T06:15:15.400Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06130345", "title": "Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "SARS-CoV-2" ], "interventions": [ { "name": "SPIKEVAX", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "ModernaTX, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 15196685, "start_date": "2023-04-14", "completion_date": "2024-08-31", "has_results": false, "last_update_posted_date": "2024-12-19", "last_synced_at": "2026-10-17T06:15:15.400Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06130345" }, { "nct_id": "NCT01788514", "title": "Combining Entertainment & Influenza Education for Pediatric Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Videogame", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "8 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "8 Years to 17 Years" }, "enrollment_count": 51, "start_date": "2013-01", "completion_date": "2014-05", "has_results": false, "last_update_posted_date": "2019-02-06", "last_synced_at": "2026-10-17T06:15:15.400Z", "location_count": 1, "location_summary": "Mineola, New York", "locations": [ { "city": "Mineola", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01788514" }, { "nct_id": "NCT02285998", "title": "Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Flublok Quadrivalent Influenza Vaccine", "type": "BIOLOGICAL" }, { "name": "Inactivated Influenza Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Protein Sciences Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 9003, "start_date": "2014-10", "completion_date": "2015-05", "has_results": true, "last_update_posted_date": "2017-10-27", "last_synced_at": "2026-10-17T06:15:15.400Z", "location_count": 38, "location_summary": "Mobile, Alabama • Tempe, Arizona • Little Rock, Arkansas + 34 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Redding", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02285998" }, { "nct_id": "NCT01006798", "title": "Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Bird Flu", "Influenza" ], "interventions": [ { "name": "Placebo", "type": "OTHER" }, { "name": "Ad4-H5-Vtn", "type": "BIOLOGICAL" }, { "name": "Sanofi Pasteur Influenza Virus Vaccine, H5N1", "type": "BIOLOGICAL" } ], "intervention_types": [ "OTHER", "BIOLOGICAL" ], "sponsor": "Emergent BioSolutions", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 166, "start_date": "2009-10", "completion_date": "2011-09", "has_results": false, "last_update_posted_date": "2024-03-18", "last_synced_at": "2026-10-17T06:15:15.400Z", "location_count": 4, "location_summary": "Lexington, Kentucky • Kansas City, Missouri • Rochester, New York + 1 more", "locations": [ { "city": "Lexington", "state": "Kentucky" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "Rochester", "state": "New York" }, { "city": "Mt. Pleasant", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01006798" }, { "nct_id": "NCT03315104", "title": "Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza A H3N2", "Influenza A H1N1" ], "interventions": [ { "name": "FLU-IGIV", "type": "BIOLOGICAL" }, { "name": "Placebo for FLU-IGIV", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Emergent BioSolutions", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 65, "start_date": "2017-11-17", "completion_date": "2019-06-17", "has_results": true, "last_update_posted_date": "2024-03-18", "last_synced_at": "2026-10-17T06:15:15.400Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Little Rock, Arkansas + 34 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Orange", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03315104" }, { "nct_id": "NCT04101838", "title": "B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Fluzone", "type": "DRUG" }, { "name": "Flucelvax", "type": "DRUG" }, { "name": "Fluzone High-Dose", "type": "DRUG" }, { "name": "Fluad", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 50, "start_date": "2021-04-01", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-05-14", "last_synced_at": "2026-10-17T06:15:15.400Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT04101838" }, { "nct_id": "NCT02342249", "title": "Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza A" ], "interventions": [ { "name": "VX-787 300 mg", "type": "DRUG" }, { "name": "VX-787 600 mg", "type": "DRUG" }, { "name": "Oseltamivir 75 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 292, "start_date": "2014-12-11", "completion_date": "2016-05-25", "has_results": false, "last_update_posted_date": "2025-02-04", "last_synced_at": "2026-10-17T06:15:15.400Z", "location_count": 129, "location_summary": "Athens, Alabama • Birmingham, Alabama • Gulf Shores, Alabama + 126 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Gulf Shores", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Scottsboro", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT02342249" }, { "nct_id": "NCT01258842", "title": "Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Bifidobacterium lactis HN019", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Fonterra Research Centre", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 426, "start_date": "2010-12", "completion_date": "2011-05", "has_results": false, "last_update_posted_date": "2010-12-13", "last_synced_at": "2026-10-17T06:15:15.400Z", "location_count": 2, "location_summary": "Coral Gables, Florida • Rochester, Michigan", "locations": [ { "city": "Coral Gables", "state": "Florida" }, { "city": "Rochester", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01258842" }, { "nct_id": "NCT01299142", "title": "Safety and Pharmacokinetics Study of Human Monoclonal Antibody (FGI-101-1A6)", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "FGI-101-1A6", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Functional Genetics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 48, "start_date": "2011-01", "completion_date": "2011-10", "has_results": false, "last_update_posted_date": "2011-02-18", "last_synced_at": "2026-10-17T06:15:15.400Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01299142" }, { "nct_id": "NCT05975840", "title": "Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Influenza, Human" ], "interventions": [ { "name": "FLU Q-PAN H5N8 375_B", "type": "BIOLOGICAL" }, { "name": "FLU Q-PAN H5N8 375_A", "type": "BIOLOGICAL" }, { "name": "FLU Q-PAN H5N8 750_B", "type": "BIOLOGICAL" }, { "name": "FLU Q-PAN H5N8 750_A", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 518, "start_date": "2023-08-03", "completion_date": "2024-09-19", "has_results": true, "last_update_posted_date": "2025-08-19", "last_synced_at": "2026-10-17T06:15:15.400Z", "location_count": 20, "location_summary": "Anniston, Alabama • Mobile, Alabama • Tempe, Arizona + 17 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05975840" } ] }